While medullary thyroid cancer remains a surgically treated malignancy, the opportunity for cure is dependent on early diagnosis and treatment. After a brief review of current treatment guidelines, panelists will participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management and those that remain controversial.

Join us for a robust discussion based CME with representation from specialties across the health system from endocrinology, pathology and laboratory, medical oncology and surgical oncology.

MODERATOR

Susan J. Mandel, MD, MPH

PANELISTS

Virginia LiVolsi, MD
Kate Nathanson, MD
Lova L. Sun, MD, MSCE
Rachel Kelz, MD, MBA

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.